Kite Pharma
Kite Pharma is a publicly held, clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. The Santa Monica, California-based company was founded in 2009 by Arie Belldegrun, M.D., FACS, an Israeli-American oncologist, who serves as the company's chairman, president and chief executive officer.
Wikipage redirect
primaryTopic
Kite Pharma
Kite Pharma is a publicly held, clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. The Santa Monica, California-based company was founded in 2009 by Arie Belldegrun, M.D., FACS, an Israeli-American oncologist, who serves as the company's chairman, president and chief executive officer.
has abstract
Kite Pharma is a publicly held ...... t and chief executive officer.
@en
founded by
founding year
industry
key person
location city
państwo
product
Link from a Wikipage to an external page
Wikipage page ID
42,800,298
Wikipage revision ID
731,660,930
comment
Kite Pharma is a publicly held ...... t and chief executive officer.
@en
label
Kite Pharma
@en
wasDerivedFrom
homepage
isPrimaryTopicOf
name
Kite Pharma, Inc.
@en